0001209191-20-050714.txt : 20200916
0001209191-20-050714.hdr.sgml : 20200916
20200916164635
ACCESSION NUMBER: 0001209191-20-050714
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200914
FILED AS OF DATE: 20200916
DATE AS OF CHANGE: 20200916
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KERINS PATRICK J
CENTRAL INDEX KEY: 0001235112
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38129
FILM NUMBER: 201179291
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Mersana Therapeutics, Inc.
CENTRAL INDEX KEY: 0001442836
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 840 MEMORIAL DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-498-0020
MAIL ADDRESS:
STREET 1: 840 MEMORIAL DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: MERSANA THERAPEUTICS INC
DATE OF NAME CHANGE: 20080813
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-09-14
1
0001442836
Mersana Therapeutics, Inc.
MRSN
0001235112
KERINS PATRICK J
1954 GREENSPRING DRIVE
SUITE 600
TIMONIUM
MD
21093
0
0
1
0
Common Stock
2020-09-14
4
J
0
2000000
0.00
D
5959520
I
See Note 2
Common Stock
2020-09-14
4
J
0
20000
0.00
A
20000
I
See Note 4
Common Stock
2020-09-14
4
J
0
20000
0.00
D
0
I
See Note 4
Common Stock
2020-09-14
4
J
0
10000
0.00
A
10000
I
See Note 7
Common Stock
2020-09-14
4
J
0
10000
0.00
D
0
I
See Note 7
Common Stock
2020-09-14
4
J
0
830
0.00
A
3222
D
Common Stock
2020-09-14
4
J
0
372
0.00
A
3594
D
New Enterprise Associates 14, L.P. ("NEA 14") made a pro rata distribution for no consideration of an aggregate of 2,000,000 shares of Common Stock of the Issuer to its general partner and its limited partners on September 14, 2020.
The Reporting Person is a director of NEA 14 GP, LTD ("NEA 14 LTD"), which is the sole general partner of NEA Partners 14, L.P. ("NEA Partners 14"). NEA Partners 14 is the sole general partner of NEA 14, which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the NEA 14 shares in which the Reporting Person has no pecuniary interest.
NEA Partners 14 received 20,000 shares of Common Stock of the Issuer in the distribution by NEA 14 on September 14, 2020.
The Reporting Person is a director of NEA 14 LTD, which is the sole general partner of NEA Partners 14, the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the NEA Partners 14 shares in which the Reporting Person has no pecuniary interest.
NEA Partners 14 made a pro rata distribution for no consideration of an aggregate of 20,000 shares of Common Stock of the Issuer to its limited partners on September 14, 2020.
NEA 14 Manager Fund, L.P. ("NEA 14 Manager Fund") received 10,000 shares of Common Stock of the Issuer in the distribution by NEA 14 on September 14, 2020.
The Reporting Person is a director of NEA 14 LTD, which is the sole general partner of NEA 14 Manager Fund. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities of the Issuer held by NEA 14 Manager Fund in which the Reporting Person has no pecuniary interest.
NEA 14 Manager Fund made a pro rata distribution for no consideration of an aggregate of 10,000 shares of Common Stock of the Issuer to its limited partners on September 14, 2020.
The Reporting Person received 830 shares of Common Stock of the Issuer in the distribution by NEA Partners 14 on September 14, 2020.
The Reporting Person received 372 shares of Common Stock of the Issuer in the distribution by NEA 14 Manager Fund on September 14, 2020.
/s/ Sasha Keough, attorney-in-fact
2020-09-16